Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000242 |
Cyclic AMP |
[VIP protein binds to VIPR2 protein] which results in increased abundance of Cyclic AMP | affects binding|increases abundance | 7733904
|
D000242 |
Cyclic AMP |
VIP protein results in increased abundance of Cyclic AMP | increases abundance | 2859561
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of VIP mRNA | affects expression | 16483693
|
D001971 |
Bromocriptine |
[Bromocriptine co-treated with vasoactive intestinal peptide, 4-chloro-Phe(6)-Leu(17)-] inhibits the reaction [Diethylstilbestrol results in increased expression of VIP protein] | affects cotreatment|decreases reaction|increases expression | 15677882
|
D001971 |
Bromocriptine |
Bromocriptine inhibits the reaction [Diethylstilbestrol results in increased expression of VIP mRNA] | decreases reaction|increases expression | 15677882
|
D001971 |
Bromocriptine |
Bromocriptine inhibits the reaction [Diethylstilbestrol results in increased expression of VIP protein] | decreases reaction|increases expression | 15677882
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [VIP protein results in increased activity of MMP2 protein] | decreases reaction|increases activity | 19189304
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [VIP protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19189304
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [VIP protein results in increased expression of CCND1 protein] | decreases reaction|increases expression | 19189304
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [VIP protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17434257
|
D003520 |
Cyclophosphamide |
VIP protein inhibits the reaction [Cyclophosphamide results in increased expression of CXCL1 protein] | decreases reaction|increases expression | 18483878
|
D003520 |
Cyclophosphamide |
VIP protein inhibits the reaction [Cyclophosphamide results in increased expression of IL1B protein] | decreases reaction|increases expression | 18483878
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in increased expression of VIP mRNA | increases expression | 15620428
|
D004054 |
Diethylstilbestrol |
[Bromocriptine co-treated with vasoactive intestinal peptide, 4-chloro-Phe(6)-Leu(17)-] inhibits the reaction [Diethylstilbestrol results in increased expression of VIP protein] | affects cotreatment|decreases reaction|increases expression | 15677882
|
D004054 |
Diethylstilbestrol |
Bromocriptine inhibits the reaction [Diethylstilbestrol results in increased expression of VIP mRNA] | decreases reaction|increases expression | 15677882
|
D004054 |
Diethylstilbestrol |
Bromocriptine inhibits the reaction [Diethylstilbestrol results in increased expression of VIP protein] | decreases reaction|increases expression | 15677882
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of VIP mRNA | increases expression | 15677882 17005392 12960047
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of VIP protein | increases expression | 12960047 15677882
|
D004054 |
Diethylstilbestrol |
vasoactive intestinal peptide, 4-chloro-Phe(6)-Leu(17)- promotes the reaction [Diethylstilbestrol results in increased expression of VIP mRNA] | increases expression|increases reaction | 15677882
|
C046318 |
dopexamine |
VIP protein affects the susceptibility to dopexamine | affects response to substance | 9890401
|
D006632 |
Histamine |
VIP protein results in increased secretion of Histamine | increases secretion | 11164953
|
C022838 |
nickel chloride |
[nickel chloride co-treated with VIP protein] results in increased secretion of VEGFA protein | affects cotreatment|increases secretion | 16563610
|
C022838 |
nickel chloride |
nickel chloride results in increased expression of VIP mRNA | increases expression | 16563610
|
C022838 |
nickel chloride |
nickel chloride results in increased expression of VIP protein | increases expression | 16563610
|
D010126 |
Ozone |
Ozone results in increased expression of VIP protein | increases expression | 15127121 15144609
|
D010269 |
Paraquat |
VIP protein results in decreased susceptibility to Paraquat | decreases response to substance | 16999955
|
D010656 |
Phenylephrine |
VIP protein affects the susceptibility to Phenylephrine | affects response to substance | 11728430
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of VIP mRNA | decreases expression | 17426115
|
D019257 |
Quinpirole |
ADCY5 protein results in increased susceptibility to [Quinpirole co-treated with VIP protein] | affects cotreatment|increases response to substance | 12223546
|
C048507 |
vasoactive intestinal peptide, 4-chloro-Phe(6)-Leu(17)- |
[Bromocriptine co-treated with vasoactive intestinal peptide, 4-chloro-Phe(6)-Leu(17)-] inhibits the reaction [Diethylstilbestrol results in increased expression of VIP protein] | affects cotreatment|decreases reaction|increases expression | 15677882
|
C048507 |
vasoactive intestinal peptide, 4-chloro-Phe(6)-Leu(17)- |
vasoactive intestinal peptide, 4-chloro-Phe(6)-Leu(17)- promotes the reaction [Diethylstilbestrol results in increased expression of VIP mRNA] | increases expression|increases reaction | 15677882
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.12 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.50 | 16434500 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.78 | 11874814 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
5.11 | 17887948 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
4.40 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.40 | 15513908 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.49 | 15469931 |
MESH:D000855 |
Anorexia |
|
Quinpirole |
6.06 | 12183048 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.11 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.61 | 15014928 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
4.84 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.84 | 15570426 |
MESH:D001249 |
Asthma |
|
Histamine |
5.53 | 16387687 |
MESH:D001249 |
Asthma |
|
Ozone |
5.53 | 16373670 17854713 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
3.32 | 18704882 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 17521630 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
4.50 | 19761891 |
MESH:D001480 |
Basal Ganglia Diseases |
|
Bromocriptine |
6.78 | 15303389 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.15 | 19483382 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.56 | 15306635 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
4.35 | 16770732 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
3.94 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
2.12 | 18593918 19250217 16243823 18462866 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.12 | 15093573 16978400 17020986 18234424 17388661 18323546 15136595 11325840 12006526 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
2.12 | 17129689 15324884 |
MESH:D016535 |
Bronchial Hyperreactivity |
marker/mechanism |
|
| 15127121 15144609 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.68 | 16777450 18417511 17626835 18315731 14754758 15516495 19059883 |
MESH:D001986 |
Bronchial Spasm |
|
Histamine |
5.85 | 18298128 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.76 | 16183385 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
3.84 | 18593918 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
3.45 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
3.45 | 16924424 15948411 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.91 | 16152834 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
2.98 | 18414057 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.54 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
2.76 | 18462866 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
3.53 | 11179087 16170337 17124262 15728586 17287366 11754973 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.83 | 19176532 |
MESH:D003092 |
Colitis |
|
Curcumin |
4.19 | 18200517 16804969 16782535 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.55 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
2.50 | 16340194 19359593 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.91 | 18497527 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
11.81 | 16037377 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
11.81 | 16002989 12952375 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.02 | 16989017 10700343 18093676 11948286 16413132 18483878 10498854 17979934 12388444 15643279 16614059 16651033 15276878 18710439 17010015 12161096 12913760 18295254 18433785 18372110 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.43 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.07 | 10990075 15331540 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.22 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
2.70 | 18403477 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
4.01 | 18204486 |
MESH:D004314 |
Down Syndrome |
marker/mechanism |
|
| 16289943 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
4.06 | 17351913 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.49 | 12083418 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.71 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
3.47 | 15700306 16804899 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
9.64 | 11006010 |
MESH:D004802 |
Eosinophilia |
|
Histamine |
9.64 | 12689652 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
7.89 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.89 | 20131406 19236843 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.66 | 16534752 16611131 15751030 16513791 16002989 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
4.00 | 18705752 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.71 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.97 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
3.48 | 17596214 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.53 | 11389073 |
MESH:D005911 |
Gliosis |
|
Paraquat |
5.19 | 11124998 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.05 | 11014644 15172196 16376943 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
3.66 | 18462866 18829502 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.54 | 20558911 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.30 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.56 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.01 | 16221962 19176532 19772884 18467677 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
5.05 | 17701891 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.79 | 16135485 17606976 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
4.06 | 18704882 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.19 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.45 | 12960047 14722030 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
3.07 | 8949925 12717712 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.56 | 18502941 12791704 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.59 | 16002989 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.36 | 16076520 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.36 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
7.16 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
7.16 | 4850670 |
MESH:D007249 |
Inflammation |
|
Curcumin |
2.89 | 16956363 18403477 17151092 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
3.21 | 18200517 18596194 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.63 | 16306350 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
4.22 | 10783313 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
3.46 | 14681315 16762066 15003126 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
4.07 | 17184923 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.58 | 18555241 |
MESH:D007938 |
Leukemia |
|
Curcumin |
6.76 | 18462866 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.76 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.50 | 18587576 18172266 17802794 17008537 17296974 17658394 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
4.21 | 16106398 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.09 | 10373061 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
4.77 | 16106398 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.99 | 10052129 11830472 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
2.52 | 18006644 17355460 18705752 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.52 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
2.61 | 16956363 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
4.59 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.59 | 16377806 15890375 20007298 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.38 | 8266340 19066396 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.86 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
2.76 | 19359593 16243823 18462866 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
2.76 | 8597069 7614698 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
5.17 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
12.72 | 18462866 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
12.72 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
12.72 | 15700306 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.60 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.17 | 11911406 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.71 | 16173963 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.55 | 16002989 |
MESH:D008545 |
Melanoma |
|
Curcumin |
4.05 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
Histamine |
4.05 | 17709802 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.81 | 16388313 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
4.16 | 17263510 |
MESH:D008607 |
Mental Retardation |
marker/mechanism |
|
| 11357950 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.14 | 10496685 |
MESH:D020326 |
Migraine without Aura |
|
Cyclic AMP |
5.16 | 11304026 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
3.51 | 19372569 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
4.94 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.52 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.14 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.95 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
4.38 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
marker/mechanism |
|
| 19189304 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
8.38 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
8.38 | 15313581 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.38 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
4.56 | 12497104 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.72 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
4.14 | 11399458 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.66 | 18462866 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.64 | 15176712 8761367 16115947 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.91 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.33 | 8291058 |
MESH:D009765 |
Obesity |
|
Curcumin |
4.60 | 19297423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.60 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.73 | 16517039 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
3.47 | 18719352 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
2.82 | 19020741 18462866 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.63 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
5.71 | 17440100 19196508 19401701 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
5.71 | 11332152 |
MESH:D010300 |
Parkinson Disease |
|
Bromocriptine |
6.24 | 18328768 9918342 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
6.24 | 11124998 16140633 15451049 16510128 12911755 15824117 11181820 11445065 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.44 | 16190885 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.14 | 16369182 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
5.20 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.68 | 16977796 15687265 |
MESH:D011014 |
Pneumonia |
|
Ozone |
11.13 | 18007984 18381685 18929643 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
11.13 | 12504350 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.80 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
4.13 | 17184923 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 19189304 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
2.77 | 18226269 11398177 18156803 18769126 12497104 15129424 10851300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.77 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.77 | 17136230 15846301 15046698 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.53 | 19168576 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
6.00 | 16636934 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
6.00 | 16324872 17997886 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.39 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
9.29 | 18379247 10666014 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
9.29 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
4.07 | 11874814 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.87 | 16458197 |
MESH:D012220 |
Rhinitis |
marker/mechanism |
|
| 12746121 |
MESH:D012220 |
Rhinitis |
|
Histamine |
4.98 | 12689652 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
4.12 | 18462866 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.83 | 16636934 |
MESH:D018805 |
Sepsis |
|
Curcumin |
4.08 | 18389075 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.72 | 7327846 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.74 | 16709447 16002989 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.53 | 16517039 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
3.50 | 16631530 19188055 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.08 | 12837982 |
MESH:D013610 |
Tachycardia |
marker/mechanism |
|
| 3261545 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
8.55 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
8.55 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
8.55 | 17306315 16712894 16452187 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
5.28 | 18462866 |
MESH:D014581 |
Urticaria |
|
Histamine |
5.05 | 18298128 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
4.04 | 16175088 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
5.20 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
4.08 | 15809267 16690809 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.45 | 16002989 16513791 |